ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Ramsay Generale De Sante

Ramsay Generale De Sante (GDS)

12.50
-0.30
(-2.34%)
Closed January 05 11:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
12.50
Bid
12.20
Ask
12.55
Volume
442
12.25 Day's Range 12.70
11.00 52 Week Range 19.85
Market Cap
Previous Close
12.80
Open
12.70
Last Trade
3
@
12.5
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
544
Shares Outstanding
110,369,389
Dividend Yield
-
PE Ratio
-25.59
Earnings Per Share (EPS)
-0.49
Revenue
5.2B
Net Profit
-53.9M

About Ramsay Generale De Sante

Sector
Gen Med & Surgical Hospitals
Industry
Gen Med & Surgical Hospitals
Headquarters
Paris, Paris, Fra
Founded
-
Ramsay Generale De Sante is listed in the Gen Med & Surgical Hospitals sector of the Euronext with ticker GDS. The last closing price for Ramsay Generale De Sante was 12.80 €. Over the last year, Ramsay Generale De Sante shares have traded in a share price range of 11.00 € to 19.85 €.

Ramsay Generale De Sante currently has 110,369,389 shares outstanding. The market capitalization of Ramsay Generale De Sante is 1.41 € billion. Ramsay Generale De Sante has a price to earnings ratio (PE ratio) of -25.59.

GDS Latest News

RAMSAY GENERALE DE SANTE : mise à disposition des documents préparatoires à l'Assemblée Générale 2024

RAMSAY GENERALE DE SANTE : mise à disposition des documents préparatoires à l'Assemblée Générale 2024 COMMUNIQUÉ DE PRESSE Paris, le 12 novembre 2024 ASSEMBLEE GENERALE MIXTE DU 12 DECEMBRE...

Ramsay Generale de Sante: preparatory documents availability for the 2024 General Meeting

Ramsay Generale de Sante: preparatory documents availability for the 2024 General Meeting PRESS RELEASE                 Paris, 12th November 2024 COMBINED GENERAL MEETING OF DECEMBER 12, 2024...

Ramsay Sante : Q1 results as of September 30, 2024

Ramsay Sante : Q1 results as of September 30, 2024 PRESS RELEASE               PRESS RELEASE                 Paris, 7th November 2024 Q1 results as of September 30, 2024 Unaudited group revenue...

RAMSAY SANTE : Résultats du premier trimestre à fin septembre 2024

RAMSAY SANTE : Résultats du premier trimestre à fin septembre 2024 COMMUNIQUÉ DE PRESSE                 Paris, le 7 novembre 2024 Résultats du premier trimestre à fin septembre 2024 Le chiffre...

RAMSAY SANTE : communiqué de mise à disposition du DEU 2024

RAMSAY SANTE : communiqué de mise à disposition du DEU 2024 COMMUNIQUÉ DE PRESSE Paris, le 30 octobre 2024          MISE À DISPOSITION DU DOCUMENT D’ENREGISTREMENT UNIVERSEL 2024 Le Document...

RAMSAY SANTE : Availability of the Universal Registration Document 2024

RAMSAY SANTE : Availability of the Universal Registration Document 2024 PRESS RELEASE                 Paris, 30th October 2024 AVAILABILITY OF THE UNIVERSAL REGISTRATION DOCUMENT 2024 Ramsay...

RAMSAY SANTE :Annual results at the end of June 2024

RAMSAY SANTE :Annual results at the end of June 2024 PRESS RELEASE                 Paris, 18th October 2024 Annual results at the end of June 2024 As a mission-driven company, Ramsay Santé...

RAMSAY SANTE : Résultats annuels au 30 juin 2024

RAMSAY SANTE : Résultats annuels au 30 juin 2024 COMMUNIQUÉ DE PRESSE                 Paris, le 18 octobre 2024 Résultats annuels à fin juin 2024 Entreprise à mission, Ramsay Santé, grâce à ses...

RAMSAY SANTE : Provisional annual results at the end of June 2024

RAMSAY SANTE : Provisional annual results at the end of June 2024 PRESS RELEASE                 Paris, 29th August 2024 Provisional annual results at the end of June 2024 As a mission-driven...

RAMSAY SANTE : résultats annuels provisoires à fin juin 2024

RAMSAY SANTE : résultats annuels provisoires à fin juin 2024 COMMUNIQUÉ DE PRESSE                 Paris, le 29 août 2024 Résultats annuels provisoires à fin juin 2024 Entreprise à mission...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
11.19.6491228070211.412.811.4100112.01167582DE
40.756.382978723411.7512.811.258011.68484895DE
120.54.166666666671213.61154411.96926523DE
26-3.4-21.383647798715.9161143812.87970832DE
52-7.3-36.868686868719.819.851183814.46980379DE
156-9-41.860465116321.526.11194219.4238628DE
260-4.6-26.900584795317.126.11194118.97308138DE

GDS - Frequently Asked Questions (FAQ)

What is the current Ramsay Generale De Sante share price?
The current share price of Ramsay Generale De Sante is 12.50 €
How many Ramsay Generale De Sante shares are in issue?
Ramsay Generale De Sante has 110,369,389 shares in issue
What is the market cap of Ramsay Generale De Sante?
The market capitalisation of Ramsay Generale De Sante is EUR 1.41B
What is the 1 year trading range for Ramsay Generale De Sante share price?
Ramsay Generale De Sante has traded in the range of 11.00 € to 19.85 € during the past year
What is the PE ratio of Ramsay Generale De Sante?
The price to earnings ratio of Ramsay Generale De Sante is -25.59
What is the cash to sales ratio of Ramsay Generale De Sante?
The cash to sales ratio of Ramsay Generale De Sante is 0.27
What is the reporting currency for Ramsay Generale De Sante?
Ramsay Generale De Sante reports financial results in EUR
What is the latest annual turnover for Ramsay Generale De Sante?
The latest annual turnover of Ramsay Generale De Sante is EUR 5.2B
What is the latest annual profit for Ramsay Generale De Sante?
The latest annual profit of Ramsay Generale De Sante is EUR -53.9M
What is the registered address of Ramsay Generale De Sante?
The registered address for Ramsay Generale De Sante is 39 RUE MSTISLAV ROSTROPOVITCH, PARIS, PARIS, 75017
What is the Ramsay Generale De Sante website address?
The website address for Ramsay Generale De Sante is www.ramsaygds.fr
Which industry sector does Ramsay Generale De Sante operate in?
Ramsay Generale De Sante operates in the GEN MED & SURGICAL HOSPITALS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLFXOFinaxo
0.895 €
(43.20%)
500
MLWEYWeya
0.0175 €
(34.62%)
5.1k
POXELPoxel
0.191 €
(33.57%)
4.22M
ALBIOBiosynex
2.50 €
(28.73%)
50.71k
SEQUASequana medical NV
3.02 €
(23.27%)
1.05M
BNBSTonner Drones
0.0005 €
(-50.00%)
524.03k
ALAGOEPango SA
0.127 €
(-41.20%)
11.94M
EIFDSTour Eiffel DS
0.0032 €
(-38.46%)
33.94k
FINMFinanciere Marjos
0.076 €
(-36.13%)
1.4k
ALALOAcheterLouerFR
0.20 €
(-33.33%)
90.63k
ATOAtos SE
0.0024 €
(-4.00%)
1.53B
BCPBanco Comercial Portugues SA
0.4623 €
(0.74%)
43.69M
ALTDTonner Drones
0.0118 €
(-7.81%)
27.49M
NEOENNeoen SA
39.74 €
(-0.15%)
21.76M
ALVERVergnet
0.002 €
(0.00%)
16.8M

Discussion

View Full Feed
nowwhat2 nowwhat2 5 minutes ago
editing
https://investorshub.advfn.com/uimage/uploads/2025/1/5/twljxtotal_3_!_5_5d_1212am_whump.jpg
XRPUSD
boi568 boi568 13 minutes ago
That spike to $31.50 was not organic and it was clearly generated by a big player. I have always thought it was an engineered mini-short squeeze.
AVXL
Mr. Bill Mr. Bill 25 minutes ago
https://www.goodrx.com/well-being/sleep/how-to-sleep-with-sciatica
nowwhat2 nowwhat2 27 minutes ago
Could still just be climbing in sympathy w overall crypto mkt

Scathingly poor outlooks

https://www.youtube.com/watch?v=EOsjnOUAw14



https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg

WONDF
DonVance DonVance 29 minutes ago
This will hit 1k this year I believe now.
MSTR
georgejjl georgejjl 29 minutes ago
How many of the 7 million Alzheimer’s patients in the USA are projected to be treated with the MAB infusions during 2025???

How many people with Alzheimer’s in the USA are projected to be treated with donepezil (Aricept) or memantine during 2025???

The treatment used t
AVXL
Mr. Bill Mr. Bill 30 minutes ago
Stretches https://www.healthline.com/health/back-pain/sciatic-stretches#sitting-spinal-stretch
Graniteguy Graniteguy 31 minutes ago
Doc and Investor posters here tend to be negatively biased which you whole heartedly champion, especially "Doc" who's medical opinion is at best questionable, and incredibly biased, to fit a narrative of constant failure for Anavex's Blarcamesine. The fact that you pile onto their "steaming pile of
AVXL
BDEZ BDEZ 33 minutes ago
The Russes hit the jackpot?
BDEZ BDEZ 34 minutes ago
40% of homicides in the US take place in districts with a Soros-funded prosecutor.

Biden gave him a Medal Of Freedom.

https://x.com/EndWokeness/status/1875725808071012529
BDEZ BDEZ 35 minutes ago
Not good, thanks for sharing.
sand sand 42 minutes ago
Thank you Ducci for all your sharing and insights extremely helpful. I'm slowly diligently getting there rewiring the brain and focusing on what shows the moves. Much continued success this week. Thank you again.
SPY
mining101 mining101 42 minutes ago
Moving hard soon 
EFSH
mining101 mining101 43 minutes ago
Superb
MEGL
benz280c benz280c 50 minutes ago
Speak louder and maybe you will convince somebody that this is how you really feel. No need to be insecure around your fellow investors.
GDVM
rx7171 rx7171 57 minutes ago
In addition MABs are approved for only a limited portion of the AD population, whereas Blarcamasine appears to be effective in 70-80% of the ITT population with its strongest efficacy in the 70% with wild type Sigma-1.
AVXL
TheHound TheHound 58 minutes ago
Learn how to use the bull market support band with that chart and you’ll have a powerful tool under your belt!
XRPUSD
Investor2014 Investor2014 1 hour ago
When I say that the totality of information is what Anavex rely on it does take into account the pretty ineffective SOC, associated risks and inconveniences for patients.

Still any drug regulatory process must and should look carefully at the data to ensure that neither type one or tw
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con
BTCUSD
rx7171 rx7171 1 hour ago
Yes that spike to $23 in June of 2021 was driven entirely by the excellent Phase II data for PDD.

Yet now after completing the AD 2b/3 trial and having an EMA MAA accepted for evaluation the share price is barely half that number!

I understand the company being very ca
PDD
sunspotter sunspotter 1 hour ago
Black Cat Moan was one of my favorites back in the day:

https://youtu.be/cxN-frB1UbI?si=Ph6XMC3omR0rRlmR

Edit: auto correct changed Moan to Moana. The cultural prevalence of Disney.
Investor2014 Investor2014 1 hour ago
The ex-biotech executive is back in the Rett trap posting mode - hope it goes better with the biased approach this time.

Listing all the site PI’s is not world class peer review WGT confirmation.
AVXL
nowwhat2 nowwhat2 1 hour ago
Just learnt of the Total 3 today.......Appears to be a good thing to have learnt of.

3 month
https://investorshub.advfn.com/uimage/uploads/2025/1/5/siwcoTOTAL_3_!_4_3M_JUNCT_DAY_1.jpg



Because how the overall mkt resolves itself is gonna'r have con

Your Recent History

Delayed Upgrade Clock